GSK Expands Immunology Pipeline Through siRNA Licensing Agreement with Frontier Biotech

Frontier Biotechnologies Inc. (hereinafter referred to as "Frontier Biotech" or "the Company") has entered into an exclusive licensing agreemen...

February 26, 2026 | Thursday | News
Azenta Partners with Frontier Space to Advance Life Sciences Research in Microgravity

Azenta, Inc.  announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge s...

February 11, 2026 | Wednesday | News
Cellares Expands Automation Platform into Gene-Edited HSC Therapies Through Stanford Medicine Collaboration

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), announced a collaboration with the Stanford Center for Definitive and C...

February 05, 2026 | Thursday | News
Origami Therapeutics and Ipsen Enter Global Collaboration to Advance Disease-Modifying Therapy for Rare Neurodegenerative Disease

- Ipsen obtains exclusive option to global license a research program for a selective disease-modifying approach to neurodegenerative diseases ...

February 02, 2026 | Monday | News
Tenacia and Golden Age Health Partner to Commercialize First-Ever Approved Treatment for CDD in China

First-ever approved treatment for CDD in China now set for commercial launch through dedicated rare disease platform Tenacia Biopharmaceutical...

February 02, 2026 | Monday | News
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities

Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capit...

January 28, 2026 | Wednesday | News
Argo Biopharma and Novartis Dose First Patient in Phase 2b Trial of siRNA Therapy BW-20829

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, announ...

January 27, 2026 | Tuesday | News
Antibodies Inc. Launches Recombinant Guinea Pig RBPMS Antibody to Advance Retinal Ganglion Cell Research

Antibodies Inc., a leading supplier of validated life science research reagents,  announced the availability of its Recombinant Guinea Pig RBPMS An...

January 23, 2026 | Friday | News
Syngene and Bristol Myers Squibb Extend Long-Standing Global R&D and Manufacturing Partnership

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the extension of its long-standing stra...

January 23, 2026 | Friday | News
Gates Foundation, Novo Nordisk Foundation, and Wellcome Launch $60M Global Consortium to Accelerate Antibiotic Discovery Against AMR

The Gates Foundation, Novo Nordisk Foundation, and Wellcome today awarded a total of $60 million in new grant funding over the next three years to resear...

January 23, 2026 | Friday | News
Parse Biosciences and Graph Therapeutics Partner to Build a Large-Scale Immune Cell Perturbation Atlas

Parse Biosciences and Graph Therapeutics (Graph) announced a strategic partnership to create one of the largest and most comprehensive immune cell pertur...

January 22, 2026 | Thursday | News
Sapio Sciences Expands ELaiN Ecosystem With Trusted Third-Party Scientific Applications Integrated Into AI Lab Notebook

Sapio Sciences, the science-awareTM AI lab informatics platform, today announced the availability of trusted, third-party scientific applications and platf...

January 14, 2026 | Wednesday | News
Stablepharma and AFT Pharmaceuticals Partner to Develop Fridge-Free Sterile Injectables for Global Markets

  Stablepharma Limited, specialists in thermostable formulations,announced a development and option-to-license agreement with AFT Pharmaceuticals to ...

January 16, 2026 | Friday | News
Rakuten Medical Partners With LOTTE Biologics to Expand Manufacturing for Alluminox® Photoimmunotherapy

  Rakuten Medical, Inc. and LOTTE Biologics announced that they have signed a biopharmaceutical contract manufacturing agreement during the J.P....

January 15, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close